CI News and Press, Cigna Corporation From 10/02/23

2023-10-02 04:59:42 ET Summary September has historically been a bad month for equities, with the SPDR S&P 500 Trust ETF and Vanguard's Dividend Appreciation ETF both posting losses during the last 4 Septembers. The top 15 dividend growth stocks for October offer an average di...

2023-10-01 20:01:28 ET More on Cigna Cigna: Buy Rating Driven By Undervaluation And Revenue Growth Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape Cigna Group: Weaker Than Peers But Still A Buy New Senate bill to raise scrutiny on ...

2023-10-01 10:09:35 ET Summary Cigna (CI) gets a Buy rating today. Strengths: dividends, valuation, revenue growth, net income & EPS, share price vs moving average, capital & liquidity. Offsetting factors:  price performance vs S&P 500. The downside risk o...

The Cigna Group Affirms Commitment to Medicare Advantage Customers; Resolves Allegations Related to Industry Risk Adjustment Practices PR Newswire BLOOMFIELD, Conn. , Sept. 29, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) announced it has...

2023-09-29 10:19:03 ET More on Walgreens Walgreens Boots Alliance, Inc. (WBA) TD Cowen's 8th Annual FutureHealth Conference (Transcript) Walgreens: Don't Be Fooled - It's Cheap For A Reason What's Next For Walgreens Boots After The CFO & CEO Step Down? P&...

2023-09-28 15:02:56 ET More on Cigna, CVS Health, etc. The Top 3 Reasons To Buy CVS Health CVS Health Is Undervalued If We Avoid Recession CVS Health: Weighing High Free Cash Flow And Bearish Price Trends CVS hit by pharmacist walkout, independent pharmacy su...

Cigna Healthcare Takes Action To Fight Food Insecurity Among Seniors PR Newswire BLOOMFIELD, Conn. , Sept. 25, 2023 /PRNewswire/ -- Cigna Healthcare, the health benefits provider of The Cigna Group (NYSE: CI), is investing $1 million in national and comm...

2023-09-24 03:32:10 ET Summary Market weakness continues due to concerns about the Federal Reserve and interest rates. Energy sector is showing signs of strength, with oil prices rising and potential for above-market returns. Market weakness during earnings "quiet periods" may...

2023-09-20 23:05:44 ET Summary Brand recognition combined with the leading market share of Blue Cross Blue Shield generates a strong competitive moat. Value-based care and increased adoption of Carelon may drive double-digit EPS growth over the next 5-years. Consolidation of v...

2023-09-19 08:59:20 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips GARP, or “Growth at a Reasonable Price,” is an investing strategy popularized by Wall Street legend Peter Lynch, who managed the Fidelity Magellan Fund (MUTF: FMAGX ...